CRYSTALLINE POLYMORPH OF A BISULFATE SALT OF A THROMBIN RECEPTOR ANTAGONIST, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THROMBIN RECEPTORS
The present invention refers to a crystalline polymorph Form 1 of Compound 2 of the formula: that exhibits a powder x-ray diffraction pattern having characteristic peak locations of 11.2, 16.4, 19.2 and 21.0 degrees 2¸.